A three-dimensional experimental system has been developed to study the response to drugs in low-grade glioma, a tumor of the central nervous system that often occurs in children.

NanoViricides CEO Dr Anil Diwan joined Steve Darling from Proactive to announce that the company has filed an application for ...

Covaris, a PerkinElmer company specializing in sample preparation technologies for the life sciences, today announced the ...

On March 17, 2026, Rocket Lab filed a prospectus supplement with the U.S. Securities and Exchange Commission to offer and ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Swaney Group Capital ("SGC"), a Tampa-based private equity firm, in partnership with LongueVue Capital ("LVC"), a New Orleans-based private equity firm, announced a strategic investment in Apex Dental ...

Clinical testing of children with suspected pediatric acute-onset neuropsychiatric syndrome does not help identify the ...

BGL's Healthcare and Life Sciences investment banking team served as the exclusive financial advisor to Apex in the transaction. Learn more here: ...

Research presented at NAPNAP 2026 discusses the rising popularity of herbal supplements among children and adolescents.

Report reveals how 24/7 integrated virtual and in-home care helps children with special health care needs have more safe days at home Imagine Pediatrics is a tech-enabled medical group delivering 24/7 ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Zai Lab (ZLAB) has drawn investor attention after a period of weaker share ...